YieldMax TSLA Option Income Strategy ETF has historically underperformed, but recent political developments involving Elon ...

I reiterate a 'Buy' rating for Zoetis with a one-year target price of $210 per share, driven by strong product performance ...

Microsoft's $13 billion partnership with OpenAI underscores its ambitious AI strategy. Click here to read why MSFT stock is a ...

Chances are high that the Bitcoin dominance has either already peaked for this cycle or will peak in November or December ...

Booz Allen Hamilton anticipates significant growth in its cybersecurity business. Read why I reiterate a Strong Buy rating ...

Microsoft's Intelligent Cloud segment sees growth from Azure AI adoption. Read why I remain bullish on MSFT stock and ...

The acquisition reshapes FREYR Battery into a profitable growth company while providing immediate revenue streams. See why ...

David Abrams’ 13F portfolio value increased from $5.11B to $6.23B in Q3 2024, with the top three stakes comprising ~66%. The ...

Meta Platforms delivered strong Q3 results, but it's not the right time to initiate a position in the company. See why META ...

Target Resources cut its dividend in 2020 to repay debt faster, reflecting its aggressive growth strategy. See why TRGP stock ...

Maxim Power's transition to a new plant and market shift increase shareholder value. Click here to read why MXG:CA stock is a ...

Global Medical REIT's Q3-2024 results show flat rental revenue and AFFO. Check out a few concerns with GMRE stock and why it ...